Loading clinical trials...
Loading clinical trials...
Identifying the Pathophysiology of Neurogenic Orthostatic Hypotension and the Effects of Melatonin on Reducing Supine Hypertension in Peripherally Intact Versus Denervated Post-ganglionic Sympathetic Nerves
Conditions
Interventions
Yohimbine
Melatonin
Locations
1
Canada
University Hospital
London, Ontario, Canada
Start Date
March 1, 2018
Primary Completion Date
May 28, 2019
Completion Date
May 28, 2019
Last Updated
June 12, 2019
NCT06647511
NCT07439939
NCT05746039
NCT07218029
NCT07098065
NCT06741436
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions